• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Dr. Kang Zhang honored with ASCI membership

Article

Salt Lake City-The American Society of Clinical Investigators (ASCI)-one of the oldest and most prestigious medical honor societies in the United States-has selected Kang Zhang, MD, PhD, as a member. Dr. Zhang is only the second ophthalmologist in the organization's 98-year history to be honored with membership.

Salt Lake City-The American Society of Clinical Investigators (ASCI)-one of the oldest and most prestigious medical honor societies in the United States-has selected Kang Zhang, MD, PhD, as a member. Dr. Zhang is only the second ophthalmologist in the organization's 98-year history to be honored with membership.

With 2,800 physician-scientists of all medical specialties, the society elects 80 new members each year for their significant achievement in biomedical research. Because members must be 45 years of age or younger at the time of their election, membership reflects accomplishments by its members relatively early in their careers.

Dr. Zhang serves as assistant professor, department of ophthalmology and visual sciences, John Moran Eye Center, University of Utah, Salt Lake City; investigator, program in human molecular biology and genetics, Eccles Institute of Human Genetics, University of Utah; and attending staff physician, Veteran's Administration Medical Center, Salt Lake City.

Related Videos
Paul Badawi, co-founder and CEO of Sight Sciences, chats with Neda Shamie, MD, about what drives him
© 2024 MJH Life Sciences

All rights reserved.